Multimodal Analysis of FDA Drug Safety Communications: Lessons from Zolpidem

• Aaron Seth KesselheimBrigham and Women's Hospital
• Michael S. SinhaBrigham and Women's Hospital
• Eric G. CampbellUniversity of Colorado Denver
• Sebastian SchneeweißBrigham and Women's Hospital
• Paula RauschUnited States Food and Drug Administration
• Brian M. LappinUnited States Food and Drug Administration
• Esther H. ZhouUnited States Food and Drug Administration
• Jerry AvornBrigham and Women's Hospital
• Gerald J. Dal PanUnited States Food and Drug Administration